DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) - ARALEZ PHARMACEUTICALS INC ownership

ARALEZ PHARMACEUTICALS INC's ticker is ARLZ and the CUSIP is 03852X100. A total of 4 filers reported holding ARALEZ PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) ownership history of ARALEZ PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2018$576,000
-76.7%
1,644,5830.0%0.02%
-76.5%
Q1 2018$2,467,000
+5.7%
1,644,5830.0%0.08%
-7.6%
Q4 2017$2,335,000
-38.0%
1,644,5830.0%0.09%
-45.9%
Q3 2017$3,766,000
+69.6%
1,644,5830.0%0.17%
+44.1%
Q2 2017$2,220,000
-36.9%
1,644,5830.0%0.12%
-13.2%
Q1 2017$3,519,000
-51.5%
1,644,5830.0%0.14%
-54.4%
Q4 2016$7,253,000
-9.1%
1,644,5830.0%0.30%
-19.7%
Q3 2016$7,976,000
+47.0%
1,644,5830.0%0.37%
+74.2%
Q2 2016$5,427,000
-7.0%
1,644,5830.0%0.21%
-14.5%
Q1 2016$5,838,0001,644,5830.25%
Other shareholders
ARALEZ PHARMACEUTICALS INC shareholders Q3 2018
NameSharesValueWeighting ↓
Rubric Capital Management, LLC 237,547$843,00013.09%
JW Asset Management, LLC 1,836,375$6,519,0004.26%
DRILL CRAIG A 339,300$1,205,0003.04%
Tiger Legatus Capital Management, LLC 1,275,000$4,526,0001.80%
Broadfin Capital, LLC 3,800,000$13,490,0001.30%
Healthcare Value Capital, LLC 175,000$621,0000.91%
Kavi Asset Management, LP 313,627$1,113,0000.87%
Healthcare Value Capital, LLC 100,000$355,0000.52%
Elk Creek Partners, LLC 1,392,746$4,944,0000.37%
Par Capital Management 5,365,000$19,046,0000.30%
View complete list of ARALEZ PHARMACEUTICALS INC shareholders